We are live on
!
Find out more
Fate Therapeutics
FATE
FATE
122 hedge funds and large institutions have $762M invested in Fate Therapeutics in 2018 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 52 increasing their positions, 33 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
58% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 33
32% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 19
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
5% more funds holding
Funds holding: 116 → 122 (+6)
4.84% more ownership
Funds ownership: 87.27% → 92.1% (+4.8%)
6% more call options, than puts
Call options by funds: $2.57M | Put options by funds: $2.43M
15% less capital invested
Capital invested by funds: $893M → $762M (-$131M)
Holders
122
Holders Change
+6
Holders Change %
+5.17%
% of All Funds
2.72%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.11%
New
25
Increased
52
Reduced
33
Closed
19
Calls
$2.57M
Puts
$2.43M
Net Calls
+$142K
Net Calls Change
-$193K
Top Buyers
| 1 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$23.3M |
| 2 |
BlackRock
New York
|
+$21.8M |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
+$11M |
| 4 |
DM
Deerfield Management
New York
|
+$6.71M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$6.32M |
